DR

Damodar Ravaji Patole

Active Director Additional Director DIN 10454519
DIN 10454519 First appointment Jun 2024 Primary industry Chemicals
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Jun 2024
Shareholding value β€’β€’β€’β€’ Premium profile

About Damodar Ravaji Patole

Data last updated:

Damodar Ravaji Patole is an Additional Director at Soraya Pharma Private Limited (since 2024). The company operates in Chemicals.

DIN 10454519
Primary Designation Additional Director
Industry Chemicals
First Appointment 17 Jun 2024
Oldest Company Age 4 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Soraya Pharma Private Limited U24231MH2021PTC371633
Additional Director17 Jun 20242021Active

Board colleagues of Damodar Ravaji Patole

NameDINCompanyDesignation
Sphurti Patole Shankar08112666Soraya Pharma Private LimitedDirector

Directorship timeline

Open interactive timeline →
Soraya Pharma Private Limited
Premium access

Shareholding and investment profile for Damodar Ravaji Patole

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Damodar Ravaji Patole

Damodar Ravaji Patole currently holds 1 directorship: Soraya Pharma Private Limited (Additional Director, since 17 Jun 2024).

Damodar Ravaji Patole was first appointed on 17 Jun 2024 as Additional Director at Soraya Pharma Private Limited.

The current boards of Damodar Ravaji Patole's companies include Sphurti Patole Shankar (Soraya Pharma Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available